arrow_back Trending Legislation
Share share

Support for Fentanyl and Xylazine Test Strips to Prevent Overdoses.

This new act aims to increase the availability of test strips for dangerous substances like fentanyl and xylazine to help prevent overdoses. Citizens may gain easier access to these tests, and first responders will be trained in their use, potentially improving public safety and reducing overdose deaths.
Key points
Facilitating access to fentanyl and xylazine test strips through opioid response programs.
Training first responders and community groups on carrying and providing access to drug test strips.
Conducting research on new test strip technologies and studying the impact of their availability on overdose rates.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
ALERT Communities Act
Print number: S 2332
Sponsor: Sen. Hassan, Margaret Wood [D-NH]
Process start date: 2025-07-17
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Support for Fentanyl and Xylazine Test Strips to Prevent Overdoses.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 2332.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-07-17.

What are the main provisions?

Key points include:

  • Facilitating access to fentanyl and xylazine test strips through opioid response programs.
  • Training first responders and community groups on carrying and providing access to drug test strips.
  • Conducting research on new test strip technologies and studying the impact of their availability on overdose rates.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hassan, Margaret Wood [D-NH].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

Analysis and Potential Impact of S 2332

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Security